| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.30B | +29.7% |
| Cost of Revenue | $513.6M | +28.5% |
| R&D Expense | $117.2M | +29.2% |
| SG&A Expense | $233.0M | +13.9% |
| Operating Income | $5.4M | +107.9% |
| Interest Expense | $371K | -94.8% |
| Pre-tax Income | -$33.1M | +55.9% |
| Income Tax | -$1.6M | +69.5% |
| Net Income | -$31.5M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $319.8M | -12.7% |
| Accounts Receivable | $322.4M | +37.1% |
| Current Assets | $685.8M | +11.2% |
| Total Assets | $1.50B | +35.3% |
| Current Liabilities | $429.5M | +115.5% |
| Long-term Debt | $197.1M | +0.4% |
| Total Liabilities | $698.9M | +60.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $198.9M | +48.6% |
| Capital Expenditures | $13.8M | -46.3% |
| Investing Cash Flow | -$124.2M | -27.3% |
| Financing Cash Flow | -$120.8M | -161.0% |
| Free Cash Flow | $185.1M | +71.2% |
| +54.8% |
| EPS (Basic) | -$0.14 | +63.2% |
| EPS (Diluted) | -$0.14 | +63.2% |
| Stockholders' Equity |
| $804.6M |
| +18.9% |